TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

QILU PHARMACEUTICAL CO., LTD.

OncologyCardiovascularInfectious Disease
Pharma

QILU PHARMACEUTICAL CO., LTD. is a pharmaceutical company focused on Oncology, Cardiovascular, Infectious Disease.

-
Since
2
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 67%
0 drugs Phase 3: 16 Phase 2: 10 Phase 1: 23
Cardiovascular 11%
0 drugs Phase 3: 3 Phase 2: 1 Phase 1: 3
Infectious Disease 9%
0 drugs Phase 3: 3 Phase 1: 2
Dermatology 9%
0 drugs Phase 3: 2 Phase 2: 2 Phase 1: 2
Immunology 4%
0 drugs Phase 3: 1 Phase 2: 1 Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Immunology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Immunology, Oncology
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular, Immunology
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
Johnson & Johnson big-pharma
Oncology, Immunology, Infectious Disease, Cardiovascular